[米卡霉素在急救部门预防和治疗皮肤感染中的应用]
[Miocamycin in the prevention and treatment of cutaneous infections in the emergency service].
作者信息
Bertinieri G, Caser L, Ceffa G, Cortese P, Martina C, Riccardi G, Calogero G
机构信息
Ospedale degli Infermi, Servizio di Pronto Soccorso e Accettazione, U.S.S.L. n. 47, Biella, Vercelli.
出版信息
Minerva Med. 1987 Nov 15;78(21):1625-7.
The efficacy and tolerability of a new macrolide, Myocamycine, were assessed in the anti-infectious prophylaxis of lacerations and contusions and in the treatment of already infected wounds or phlegmons. A total of 175 patients were treated. Side effects induced the suspension of treatment in 8% of cases while the drug proved effective in preventing the infection of wounds at risk in 98% and curing existing infections in 100%.
一种新型大环内酯类药物麦考米星（Myocamycine）的疗效和耐受性在撕裂伤和挫伤的抗感染预防以及已感染伤口或蜂窝织炎的治疗中进行了评估。总共治疗了175例患者。副作用导致8%的病例中止治疗，而该药物在预防98%有感染风险的伤口感染以及治愈100%的现有感染方面证明是有效的。
Zotero 插件